Are you Dr. Stewart?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
395 Grand St
Jersey City, NJ 07302Phone+1 201-915-2600Fax+1 201-369-6301
Summary
- Dr. Michael Stewart, MD is a board certified psychiatrist in Jersey City, New Jersey. He is currently licensed to practice medicine in New Jersey and New York. He is affiliated with Greystone Park Psychiatric Hospital.
Education & Training
New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Child and Adolescent Psychiatry, 1998 - 2000
Rutgers Health/New Jersey Medical SchoolResidency, Psychiatry, 1994 - 1998- Rutgers New Jersey Medical SchoolClass of 1994
Certifications & Licensure
NJ State Medical License 2000 - 2025
NY State Medical License 1999 - 2024- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- 83 citationsLong-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 yearsFabio Barroso, Daniel P. Judge, Ben Ebede, Huihua Li, Michelle Stewart
Amyloid. 2017-07-31 - 123 citationsEstimating the global prevalence of transthyretin familial amyloid polyneuropathy.Hartmut Schmidt, Márcia Waddington-Cruz, Marc F. Botteman, John A. Carter, Avijeet S. Chopra
Muscle & Nerve. 2018-02-01 - 43 citationsTafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.Denis Keohane, Jeffrey H. Schwartz, Balarama Gundapaneni, Michelle Stewart, Leslie Amass
Amyloid. 2017-04-10
Professional Memberships
- Member
